Plenary lectures
- Dr. George F. Koob:
Alcohol Use Disorder: The Gain in the Brain is in the Emotional Pain and Implications for Treatment - recording - Dr. Haruo Naito:
Spirit of Drug Discovery - recording
- Prof. Gabriella Gobbi:
Cannabis and mood disorders - recording
- Dr. Joshua A. Gordon:
Challenges and Opportunities in Mental Health Research - recording
- Prof. Belinda Lennox:
Brains on fire? The autoimmune basis of severe mental illness - recording
- Prof. W. Wolfgang Fleischhacker:
The pharmacological treatment of schizophrenia across the life cycle - recording - recording
- Dr. Virginia Man-Yee Lee:
Transmission of Misfolded Proteins in Neurodegenerative Disorders: A Common Mechanism of Disease Progression - recording
Spotlight Sessions & Symposia
Spotlight Session 3:
Recent Topics in Research and Development of Drugs for Treating Neuropsychiatric Disorders
- Ken Kramer:
Exploring Muscarinic Receptors in Schizophrenia: A Renewed Approach to Developing Innovative Antipsychotics That Go Beyond Dopamine Receptor Antagonism
- Malaak Brubaker:
Brexpiprazole: A Review of the New Treatment Approved for Agitation Associated with Dementia due to Alzheimer‘s Disease
- Teiji Kimura:
Exploring Innovative Avenues in the Treatment of Alzheimer's Disease
Symposium 1:
Risk and Resilience in PTSD: Analyzing Trajectories and New Treatment Approaches
- Lisa Burback:
Emerging Approaches and Interventions to PTSD
- Masanori Nagamine:
Trajectories and their risk factors of post-traumatic stress symptoms among the Japan Self-Defense Force personnel deployed to humanitarian assistance missions.
- Iryna Frankova:
Emerging Approaches to Veterans after War in Ukraine - Novel Use of Ketamine in PTSD
Symposium 6:
Novel therapies to treat bipolar disorder: translation and back-translation between preclinical and clinical studies
- Tadafumi Kato:
Search for new treatment options of bipolar disorder using model mice
- Jee Hyun Kim:
Trimetazidine to treat the brain and the heart in bipolar depression
- Lakshmi Yatham:
Modulating dopamine Transporter as a therapeutic target for bipolar disorder
Symposium 10:
The antidepressant effect and mode of action of psilocybin – clinical trial and molecular imaging data from studies in man and pig
- Guy Goodwin:
The clinical effect and side-effects of psilocybin in Treatment Resistant Depression
- Friederike Holze:
The relation between acute effects of altered state, 5-HT2A binding and synaptic plasticity in large animals and healthy control subjects
- Johan Lundberg:
Translational response biomarkers examined in an RCT of psilocybin treatment of depression
Symposium 15:
New Insights on Cannabis Use and Clinical Implications: Translational Perspective
- Markus Leweke:
The significance of THC and CBD on the lipidome
- Romina Mizrahi:
In Vivo Imaging of Translocator Protein in Long-term Cannabis Users
- Ke Xu:
THC alters single cell transcriptome in immune cells
Symposium 20:
Dysfunction of Glutamate, Dopamine, and GABA Neurotransmission in Schizophrenia: Integrative View for Pathophysiologic Analysis and Innovative Treatment
- Toru Nishikawa:
Interactions Among NMDA receptor-D-serine System, Dopamine and GABA Neurotransmission in the Pathophysiology and Treatment Development in Schizophrenia - Joseph T Coyle:
The Centrality of the Glutamatergic Synapse in the Pathophysiology of Schizophrenia - Kim Q. Do:
Neurocognition and NMDA receptor co-agonists pathways in individuals with treatment resistant first-episode psychosis
CCMTV Interviews
